EUVIMEDEUVIMED entdecken
CrossrefInfokarte

High enrollment and representativeness of MACS and WIHS study participants in the newly merged MACS/WIHS Combined Cohort Study

Gypsyamber D’Souza, Ryan Herrschaft, Phyllis C Tien, Todd T Brown, Seble G Kassaye, Sabina Haberlen, Brad Aouizerat, Catalina Ramirez, Matthew J Mimiaga, Audrey L French, Charles R Rinaldo, Anjali Sharma, Margaret A Fischl, Valentina Stosor, Igho Ofotokun, Jacquett Batson, Susan Holman, Mirjam-Colette Kempf

AJE Advances: Research in Epidemiology · 2026

DOI: 10.1093/ajeadv/uuaf025 ↗
AbstractBibliografische Angaben

Abstract

Abstract The MACS and WIHS cohort studies merged to form the MACS/WIHS Combined Cohort Study (MWCCS) in 2019. We calculated the proportion of active MACS and WIHS participants seen October 2017-September 2019 (pre-merger) who enrolled in the MWCCS between October 2020-September 2024. Pre-merger, there were 4286 active participants: MACS (N=2038) and WIHS (N=2248). Complementary log-log regression was used to estimate factors associated with enrollment. Active participants pre-merger were 54% female, 62% living with HIV, 78% aged 45-74 years, with a median study follow-up of 17 years. Most historic MACS (81%) and WIHS (89%) participants enrolled in MWCCS, with 75% enrolling during the first year. Enrollment did not significantly differ by HIV serostatus, behavioral or socio-demographic characteristics. Most health-related factors were not associated with enrollment, including comorbidities (e.g., diabetes, hypertension) and HIV-specific clinical factors (i.e., CD4+ T cell count, viral suppression, antiretroviral therapy use). Factors associated with lower enrollment included age ≥75 years (aHR=0.68, 95%CI=0.55-0.83) and being underweight (BMI<18.5 kg/m2), (aHR=0.64, 95%CI=0.45-0.88). Despite challenges inherent in merging two long-standing cohorts and with enrollment beginning during the COVID-19 pandemic, overall high retention across key participant characteristics demonstrate a strong foundation for the continued study of HIV-related morbidity and mortality in the MWCCS.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →